Dapagliflozin DPPIV Inhibitor add-on Study This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metfor...

• Country Argentina, Germany, Mexico, Poland, United Kingdom, United States
• organs None
• Specialty None